Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells
- PMID: 19088370
- DOI: 10.1177/1933719108324134
Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells
Abstract
Given that prolonged exposure to unopposed estrogen has been implicated in endometrial carcinogenesis, our goal was to evaluate the effect of As(2)O(3) on regulation of estrogen receptor-alpha (ERa) expression in endometrial cancer cells. As(2)O(3) inhibited ER- mRNA and protein expression in a dose-dependent manner in both the Ishikawa and ECC-1 endometrial cancer cell lines. Treatment with As(2)O(3) resulted in rapid phosphorylation of the p42/p44 MAPK which could be abolished by addition of the MAPK inhibitor, U0126. Although treatment with U0126 alone resulted in up-regulation of ER- mRNA and protein, exposure to U0126 in combination with As(2)O(3) counteracted As(2)O(3)'s inhibitory effect on ER- expression. We provide evidence that As(2)O(3) inhibits ER- mRNA and protein expression in endometrial cancer cells, potentially through interaction with the MAPK pathway. Thus, As(2)O(3) may be valuable for its anti-estrogenic activity in combination with its anti-tumorigenic effects and be a novel therapeutic agent for endometrial cancer.
Similar articles
-
Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.Endocr Relat Cancer. 2009 Mar;16(1):113-22. doi: 10.1677/ERC-08-0117. Epub 2008 Oct 13. Endocr Relat Cancer. 2009. PMID: 18852162
-
Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.Cancer Res. 2006 Apr 1;66(7):3903-11. doi: 10.1158/0008-5472.CAN-05-4363. Cancer Res. 2006. PMID: 16585219
-
Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.Gynecol Oncol. 2007 Apr;105(1):218-22. doi: 10.1016/j.ygyno.2006.11.027. Epub 2007 Feb 2. Gynecol Oncol. 2007. PMID: 17275888
-
Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.Cancer Res. 2006 Jul 1;66(13):6763-71. doi: 10.1158/0008-5472.CAN-05-3699. Cancer Res. 2006. PMID: 16818652
-
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.Horm Cancer. 2019 Jun;10(2-3):51-63. doi: 10.1007/s12672-019-0358-9. Epub 2019 Feb 2. Horm Cancer. 2019. PMID: 30712080 Free PMC article. Review.
Cited by
-
Roles of estrogen receptor α in endometrial carcinoma (Review).Oncol Lett. 2023 Oct 25;26(6):530. doi: 10.3892/ol.2023.14117. eCollection 2023 Dec. Oncol Lett. 2023. PMID: 38020303 Free PMC article. Review.
-
A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.Front Immunol. 2022 Nov 16;13:1018544. doi: 10.3389/fimmu.2022.1018544. eCollection 2022. Front Immunol. 2022. PMID: 36466815 Free PMC article.
-
Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus.Psychopharmacology (Berl). 2021 Sep;238(9):2485-2502. doi: 10.1007/s00213-021-05871-2. Epub 2021 May 28. Psychopharmacology (Berl). 2021. PMID: 34050381
-
Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein.Cell Cycle. 2017;16(21):2058-2072. doi: 10.1080/15384101.2017.1338221. Epub 2017 Sep 28. Cell Cycle. 2017. PMID: 28880708 Free PMC article.
-
Chronic exposure to arsenic, LINE-1 hypomethylation, and blood pressure: a cross-sectional study in Bangladesh.Environ Health. 2017 Mar 7;16(1):20. doi: 10.1186/s12940-017-0231-7. Environ Health. 2017. PMID: 28270149 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials